Background. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity than
Tumors of the pineal and suprasellar region: Childrens cancer study group treatment results 1960–1975. A report from childrens cancer study group
✍ Scribed by William M. Wara; Derek T. Jenkin; Audrey Evans; Inta Ertel; Robert Hittle; Jorge Ortega; Charles B. Wilson; Denman Hammond
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 274 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The purpose of this study was to evaluate the effect of the sequential addition of doxorubicin and cyclophosphamide to the combination of vincristine and actinomycin D o n the relapse-free survival of children with stage IV/favorable histology Wilms tumor. We reviewed the clinical courses of all ran
## BACKGROUND. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity
promising salvage regimen. Continued accrual of patients and increased duration of follow-up has resulted in substantial experience with VETOPEC.